loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 209193 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 DEXCEL (2)

filter

01 TABLET, EXTENDED RELEASE;ORAL (2)

filter

01 RX (2)

filter

01 VENLAFAXINE HYDROCHLORIDE (2)

filter

01 No (2)

URL Supplier Web Content
TABLET, EXTENDED R...
EQ 225MG BASE
2019-10-31
209193
VENLAFAXINE HYDROC...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, EXTENDED R...
EQ 150MG BASE
2019-10-31
209193
VENLAFAXINE HYDROC...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 209193

Looking for FDA Orange Book APPLICATION 209193 2

19

Dexcel Pharma, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is VENLAFAXINE HYDROCHLORIDE, with a corresponding application number 209193.

Regulatory Information RX

With a dosage strength EQ 225MG BASE

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2019-10-31

Therapeutic Equivalence (TE) Code AB

18

Dexcel Pharma, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is VENLAFAXINE HYDROCHLORIDE, with a corresponding application number 209193.

Regulatory Information RX

With a dosage strength EQ 150MG BASE

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2019-10-31

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY